Search
Returning search results with filters:
Remove filter for
Last updated: April 2019
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 11 of 11 items.
Undeclared drug ingredients may pose serious health risks
Starting date:
April 30, 2019
Posting date:…
AlertForeign product alert | 2019-04-30
Multiple unauthorized prescription drugs seized from Vanier store in Ottawa, Ontario, may pose serious health risks
Starting date:
April 25, 2019
Posting date:
April 25, 2019…
AlertPublic advisory | 2019-04-25
Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tablets because of nitrosamine impurity
Starting date:
April 18, 2019
Type of communication:
Information…
AlertInformation update | 2019-04-18
Unauthorized products may pose serious health risks (December 10, 2018 to April 17, 2019)
Starting date:
December 10,…
AlertPublic advisory | 2019-04-17
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
Starting date:
April 17, 2019
Posting date:
April 17, 2019
Type…
AlertHealth professional risk communication | 2019-04-17
Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory
Starting date:
April 16, 2019
Type of communication:
Information Update…
AlertInformation update | 2019-04-16
Multiple unauthorized eye solutions and an acne gel sold at two stores in the Lower Mainland of BC may pose serious health risks…
AlertPublic advisory | 2019-04-15
Health Canada testing identifies additional health risks involving unauthorized products sold by A1 Herbal Ayurvedic Clinic Ltd…
AlertInformation update | 2019-04-12
Multiple unauthorized health products sold at Sunrise Lee Chinese Herbs Centre in Calgary, Alberta, may pose serious health risks…
AlertPublic advisory | 2019-04-05
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
Starting date:
April 4, 2019
Posting date:
April 4, 2019
Type of…
AlertHealth professional risk communication | 2019-04-04
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
Starting date:
April 4, 2019
Type of communication…
AlertInformation update | 2019-04-04